Advertisement
Advertisement
U.S. markets open in 41 minutes
Advertisement
Advertisement
Advertisement
Advertisement

PLx Pharma Inc. (PLXP)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.3400-0.0200 (-0.85%)
At close: 04:00PM EDT
2.3400 0.00 (0.00%)
After hours: 04:47PM EDT
Advertisement

PLx Pharma Inc.

9 Fishers Lane
Suite E
Sparta, NJ 07871
United States
973 409 6541
https://plxpharma.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees16

Key Executives

NameTitlePayExercisedYear Born
Mr. Michael J. ValentinoExec. Chairman393.75kN/A1954
Ms. Natasha GiordanoCEO, Pres & Director884.88kN/A1960
Ms. Rita M. O'Connor CPA, CPACFO and Head of Manufacturing & Supply Chain623.23kN/A1968
Mr. Ronald R. ZimmermanFounder & Sr. AdvisorN/AN/A1953
Mr. Tom LongVP of Manufacturing & Technical OperationsN/AN/AN/A
Ms. Janet M. BarthVP of Investor Relations & Corp. CommunicationsN/AN/AN/A
Ms. Joanne CotignolaVP of MarketingN/AN/AN/A
Ms. Nicole GodinoNational Sales DirectorN/AN/AN/A
Mr. Patrick M. LonerganMember of Chief Exec. Officer Advisory GroupN/AN/A1935
Mr. Charles Edmund Sheedy C.F.A., CFAMember of Chief Exec. Officer Advisory GroupN/AN/A1947
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.

Corporate Governance

PLx Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement